ComplianceOnline Announces Seminar on FDA Compliant GLP for Nonclinical Studies
Online, August 28, 2012 (Newswire.com) - ComplianceOnline, the leading governance, risk and compliance advisory network with over 500 experts in various regulatory subjects, today announced a seminar on FDA Compliant GLP for Nonclinical Studies - For Pharmaceutical and Medical Device Industries. The one-and-a-half day long, in-person seminar, led by regulatory expert and RAPS faculty member Dr. David Lim, will be held on July 26 and 27,2012 in Orlando, FL.
The seminar will help attendees comprehensively understand Good Laboratory Practice (GLP) regulations and achieve compliance. The course has been pre-approved by RAPS and participants will be eligible to receive up to 10 RAC credits toward their certification on completion.
Seminar instructor Dr. David Lim is a Ph.D. in biological sciences. He has held various positions at Duke, US National Laboratories, Intrexon Corporation, Terumo, US FDA/CDRH, and EraGen Biosciences, Inc. Currently, Dr. Lim is serving as a faculty at the Regulatory Affairs Professional Society (RAPS) and is an advisor to the Presidents and CEOs of FDA-regulated industry.
During this interactive workshop, Dr. Lim will explain the relevant and applicable US regulations, regulatory requirements and guidance necessary for GLP compliance. This workshop is intended to provide guidance on GLPs for conducting nonclinical laboratory studies that support or are intended to support applications for research or marketing permits for pharmaceutical and medical device products for human use regulated by the FDA. On the second day .
This course will benefit anyone in FDA-regulated industry, including, but not limited to, handling nonclinical laboratory data and documents concerning animal and human drugs, biologics, biosimilars, medical devices or any combination products thereof.
pharmaceutical and medical device products for humanuse regulated the FDA